📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults. (2021)

First Author: Veenith T

Attributed to: CATALYST a randomised early phase adaptive trial for new drugs for SARS-CoV-2+ patients funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-050202

PubMed Identifier: 34764169

Publication URI: http://europepmc.org/abstract/MED/34764169

Type: Journal Article/Review

Volume: 11

Parent Publication: BMJ open

Issue: 11

ISSN: 2044-6055